Scaleable production of adenoviral vectors by transfection of adherent PER.C6 cells

Biotechnology Progress

Volumn 23, Issue 5, 2007, Pages 1210-1217

  Subramanian, Shyamsundar ^a   Kim, Jong Joseph ^a,b   Harding, Frances ^a   Altaras, Gina M ^a   Aunins, John G ^a   Zhou, Weichang ^a,c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b VGX Pharmaceuticals Inc   (United States)

^c PDL BioPharma Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; DNA; GENETIC ENGINEERING; VACCINES;

ADENOVIRAL VECTORS; PLASMID CONSTRUCTION; TRANSFECTION;

VIRUSES;

ADENOVIRUS; ARTICLE; CELL ADHESION; CELL LINE; CULTURE TECHNIQUE; GENETIC TRANSFECTION; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METHODOLOGY; PILOT STUDY; VIRUS CULTURE;

ADENOVIRIDAE; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL LINE; PILOT PROJECTS; TRANSFECTION; VIRUS CULTIVATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 35348869726     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp0701620     Document Type: Article

References (27)

1. Shiver, J. W.; Fu, T. M.; Chen, L.; Casimiro, D. R.; Davies, M. E.; Evans, R. K.; Zhang, Z. Q.; Simon, A. J.; Trigona, W. L.; Dubey, S. A.; Huang, L. Y.; Harris, V. A.; Long, R. S.; Liang, X. P.; Handt, L.; Schleif, W. A.; Zhu, L.; Freed, D. C.; Persaud, N. V.; Guan, L.; Punt, K. S.; Tang, A.; Chen, M. C.; Wilson, K. A.; Collins, K. B.; Heidecker, G. J.; Fernandez, V. R.; Perry, H. C.; Joyce, J. G.; Grimm, K. M.; Cook, J. C.; Keller, P. M.; Kresock, D. S.; Mach, H.; Troutman, R. D.; Isopi, L. A.; Williams, D. M.; Xu, Z.; Bohannon, K. E.; Volkin, D. B.; Montefiori, D. C.; Miura, A.; Krivulka, G. R.; Lifton, M. A.; Kuroda, M. J.; Schmitz, J. E.; Letvin, N. L.; Caulfield, M. J.; Bett, A. J.; Youil, R.; Kaslow, D. C.; Emini, E. A. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 2002, 415, 331-335.
2. Mountain, A. Gene therapy: the first decade. Trends Biotechnol. 2000, 18, 119-128.
3. Polo, J. M.; Dubensky, T. W., Jr. Virus-based vectors for human vaccine applications. Drug Discovery Today 2002, 7, 719-727.
4. Cote, J.; Garnier, A.; Massie, B.; Kamen, A. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. Biotechnol. Bioeng. 1998, 59, 567-575.
5. Iyer, P.; Ostrove, J. M.; Vacante, D. Comparison of manufacturing techniques for adenovirus production. Cytotechnology 1999, 30, 169-172.
6. Schoofs, G.; Monica, T. J.; Ayala, J.; Horwitz, J.; Montgomery, T.; Roth, G.; Castillo, F. J. A high-yielding serum-free, suspension cell culture process to manufacture recombinant adenoviral vectors for gene therapy. Cytotechnology 1998, 28, 81-89.
7. Xie, L.; Metallo, C.; Warren, J.; Pilbrough, W.; Peltier, J.; Zhong, T.; Pikus, L.; Yancy, A.; Leung, J.; Aunins, J. G.; Zhou, W. Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER. C6 cell culture under sparging conditions. Biotechnol. Bioeng. 2003, 83, 45-52.
8. Chartier, C.; Degryse, E.; Gantzer, M.; Dieterle, A.; Pavirani, A.; Mehtali, M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 1996, 70, 4805-4810.
9. He, T. C.; Zhou, S. B.; da Costa, L. T.; Yu, J.; Kinzler, K. W.; Vogelstein, B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 2509-2514.
10. Youil, R.; Toner, T. J.; Su, Q.; Kaslow, D. C. Rapid method for the isolation of full length adenoviral genomes by bacterial intermolecular homologous recombination. J. Virol. Methods 2001, 92, 91-97.
11. Graham, F. L.; van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus-5 DNA. Virology 1988, 52, 456-467.
12. Girard, P.; Derouazi, M.; Baumgartner, G.; Bourgeois, M.; Jordan, M.; Jacko, B.; Wurm, F. M. 100-liter transient transfection. Cytotechnology 2002, 38, 15-21.
13. Girard, P.; Porte, L.; Berta, T.; Jordan, M.; Wurm, F. M. Calcium phosphate transfection optimization for serum-free suspension culture. Cytotechnology 2001, 35, 175-180.
14. Jordan, M.; Kohne, C.; Wurm, F. M. Calcium-phosphate mediated DNA transfer into HEK-293 cells in suspension: control of physicochemical parameters allows transfection in stirred media - Transfection and protein expression in mammalian cells. Cytotechnology 1998, 26, 39-47.
15. Meissner, P.; Pick, H.; Kulangara, A.; Chatellard, P.; Friedrich, K.; Wurm, F. M. Transient gene expression: Recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol. Bioeng. 2001, 75, 197-203.
16. Wurm, F.; Bernard, A. Large-scale transient expression in mammalian cells for recombinant protein production. Curr. Opin. Biotechnol. 1999, 10, 156-159.
17. Chen, C.; Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 1987, 7, 2745-2752.
18. Jordan, M.; Schallhorn, A.; Wurm, F. M. Transfecting mammalian cells: Optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 1996, 24, 596-601.
19. O'Mahoney, J. V.; Adams, T. E. Optimization of experimental variables influencing reporter gene expression in hepatoma cells following calcium phosphate transfection. DNA Cell Biol. 1994, 13, 1227-1232.
20. Wilson, S. P.; Liu, F.; Wilson, R. E.; Housley, P. R. Optimization of calcium phosphate transfection for bovine chromaffin cells: relationship to calcium phosphate precipitate formation. Anal. Biochem. 1995, 226, 212-220.
21. Wigand R, Kumel G. The kinetics of adenovirus infection and spread in cell cultures infected with low multiplicity. Arch. Virol. 1977, 54, 177-187.
22. Fallaux, F. J.; Bout, A.; van d, V. I.; Van den Wollenberg, D. J.; Hehir, K. M.; Keegan, J.; Auger, C.; Cramer, S. J.; van Ormondt, H.; van der Eb, A. J.; Valerio, D.; Hoeben, R. C. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 1998, 9, 1909-1917.
23. Blanche, F.; Cameron, B.; Barbot, A.; Ferrero, L.; Guillemin, T.; Guyot, S.; Somarriba, S.; Bisch, D. An improved anion-exchange HPLC method for the detection and purification of adenoviral particles. Gene Ther. 2000, 7, 1055-1062.
24. Youil, R.; Toner, T. J.; Su, Q.; Casimiro, D.; Shiver, J. W.; Chen, L.; Bett, A. J.; Rogers, B. M.; Burden, E. C.; Tang, A.; Chen, M.; Emini, E. A.; Kaslow, D. C.; Aunins, J. G.; Altaras, N. E. Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses. Hum. Gene Ther. 2003, 14, 1017-1034.
25. Shabram, P. W.; Giroux, D. D.; Goudreau, A. M.; Gregory, R. J.; Horn, M. T.; Huyghe, B. G.; Liu, X. D.; Nunnally, M. H.; Sugarman, B. J.; Sutjipto, S. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum. Gene Ther. 1997, 8, 453-465.
26. Wang, F.; Puddy, A. C.; Mathis, B. C.; Montalvo, A. G.; Louis, A. A.; McMackin, J. L.; Xu, J.; Zhang, Y.; Tan, C. Y.; Schofield, T. L.; Wolf, J. J.; Lewis, J. A. Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency. Vaccine 2005, 23, 4500-4508.
27. Subramanian, S.; Altaras, G. M.; Chen, J.; Hughes, B. S.; Zhou, W.; Altaras, N. E. Pilot-scale adenovirus seed production through concurrent virus release and concentration by hollow fiber filtration. Biotechnol. Prog. 2005, 21, 851-859.